Exploring the Pharmacological Mechanisms of Tripterygium wilfordii Hook F against Cardiovascular Disease Using Network Pharmacology and Molecular Docking
- PMID: 34435046
- PMCID: PMC8382521
- DOI: 10.1155/2021/5575621
Exploring the Pharmacological Mechanisms of Tripterygium wilfordii Hook F against Cardiovascular Disease Using Network Pharmacology and Molecular Docking
Abstract
Background: Tripterygium wilfordii Hook F (TwHF) has been used in traditional Chinese medicine (TCM) for treating cardiovascular disease (CVD). However, the underlying pharmacological mechanisms of the effects of TwHF on CVD remain elusive. This study revealed the pharmacological mechanisms of TwHF acting on CVD based on a pharmacology approach.
Materials and methods: The active compounds were selected from the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database according to the absorption, distribution, metabolism, and excretion (ADME). The potential targets of TwHF were obtained from the SwissTargetPrediction database. The CVD-related therapeutic targets were collected from the DrugBank, the GeneCards database, and the OMIM database. Protein-protein interaction (PPI) network was generated by the STITCH database. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed by R package. The network of drug-targets-diseases-pathways was constructed by the Cytoscape software.
Results: The 41 effective ingredients of TwHF and the 178 common targets of TwHF and CVD-related were collected. Furthermore, AKT1, amyloid precursor protein (APP), mitogen-activated protein kinase 1 (MAPK), phosphatidylinositol 3-kinase catalytic subunit alpha (PIK3CA), and cellular tumor antigen p53 (TP53) were identified as the core targets involved in the mechanism of TwHF on CVD. Top ten GO (biological processes, cellular components, and molecular functions) and KEGG pathways were screened with a P value ≤0.01. Finally, we constructed the network of TwHF-targets-CVD-GO-KEGG.
Conclusions: These findings demonstrate that the main active compound of TwHF, the core targets, and pathways maybe provide new insights into the development of a natural therapy for the prevention and treatment of CVD.
Copyright © 2021 Bingwu Huang et al.
Conflict of interest statement
The authors report no relationships that could be construed as a conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8382521/bin/BMRI2021-5575621.001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8382521/bin/BMRI2021-5575621.002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8382521/bin/BMRI2021-5575621.003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8382521/bin/BMRI2021-5575621.004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8382521/bin/BMRI2021-5575621.005.gif)
Similar articles
-
A Network Pharmacology-Based Strategy for Unveiling the Mechanisms of Tripterygium Wilfordii Hook F against Diabetic Kidney Disease.J Diabetes Res. 2020 Nov 20;2020:2421631. doi: 10.1155/2020/2421631. eCollection 2020. J Diabetes Res. 2020. PMID: 33274236 Free PMC article.
-
Mechanisms of Tripterygium wilfordii Hook F on treating rheumatoid arthritis explored by network pharmacology analysis and molecular docking.Open Med (Wars). 2024 May 30;19(1):20240967. doi: 10.1515/med-2024-0967. eCollection 2024. Open Med (Wars). 2024. PMID: 38841174 Free PMC article.
-
Based on Network Pharmacology Tools to Investigate the Mechanism of Tripterygium wilfordii Against IgA Nephropathy.Front Med (Lausanne). 2021 Dec 15;8:794962. doi: 10.3389/fmed.2021.794962. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34977095 Free PMC article.
-
Exploration of the mechanism of Zisheng Shenqi decoction against gout arthritis using network pharmacology.Comput Biol Chem. 2021 Feb;90:107358. doi: 10.1016/j.compbiolchem.2020.107358. Epub 2020 Aug 8. Comput Biol Chem. 2021. PMID: 33243703 Review.
-
[Progress of effect and mechanisms of Tripterygium wilfordii on immune system].Zhongguo Zhong Yao Za Zhi. 2019 Aug;44(16):3374-3383. doi: 10.19540/j.cnki.cjcmm.20190419.401. Zhongguo Zhong Yao Za Zhi. 2019. PMID: 31602898 Review. Chinese.
Cited by
-
Revealing the mechanism of quinoa on type 2 diabetes based on intestinal flora and taste pathways.Food Sci Nutr. 2023 Sep 23;11(12):7930-7945. doi: 10.1002/fsn3.3710. eCollection 2023 Dec. Food Sci Nutr. 2023. PMID: 38107122 Free PMC article.
-
Exploring the pharmacological mechanisms of Tripterygium wilfordii against diabetic kidney disease using network pharmacology and molecular docking.Heliyon. 2023 Jun 21;9(6):e17550. doi: 10.1016/j.heliyon.2023.e17550. eCollection 2023 Jun. Heliyon. 2023. PMID: 37416640 Free PMC article.
References
-
- Olvera Lopez E., Ballard B. D., Jan A. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2020, StatPearls Publishing LLC; 2020. Cardiovascular Disease.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous